NOVARTIS INDIA
|
NOVARTIS INDIA Last 5 Year Cashflow Statement History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Profit Before Tax | ₹115 Cr | ₹-3.82 Cr | ₹40 Cr | ₹29 Cr | ₹86 Cr |
Adjustment | ₹-49 Cr | ₹-5.64 Cr | ₹-4.98 Cr | ₹-12 Cr | ₹-73 Cr |
Changes In working Capital | ₹-24 Cr | ₹67 Cr | ₹-69 Cr | ₹-1.85 Cr | ₹-162 Cr |
Cash Flow after changes in Working Capital | ₹42 Cr | ₹57 Cr | ₹-34 Cr | ₹15 Cr | ₹-149 Cr |
Cash Flow from Operating Activities | ₹45 Cr | ₹39 Cr | ₹-69 Cr | ₹-23 Cr | ₹-194 Cr |
Cash Flow from Investing Activities | ₹-153 Cr | ₹87 Cr | ₹95 Cr | ₹56 Cr | ₹274 Cr |
Cash Flow from Financing Activities | ₹-30 Cr | ₹-36 Cr | ₹-37 Cr | ₹-41 Cr | ₹-30 Cr |
Net Cash Inflow / Outflow | ₹-139 Cr | ₹90 Cr | ₹-11 Cr | ₹-8.64 Cr | ₹50 Cr |
Opening Cash & Cash Equivalents | ₹158 Cr | ₹68 Cr | ₹79 Cr | ₹88 Cr | ₹38 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹19 Cr | ₹158 Cr | ₹68 Cr | ₹79 Cr | ₹88 Cr |
Compare Cashflow Statement of peers of NOVARTIS INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NOVARTIS INDIA | ₹2,534.7 Cr | 3.9% | 2.7% | 80.7% | Stock Analytics | |
ADANI ENTERPRISES | ₹346,885.0 Cr | 1.8% | -4.9% | 70.2% | Stock Analytics | |
REDINGTON | ₹17,230.3 Cr | 2.5% | -1.3% | 27% | Stock Analytics | |
HONASA CONSUMER | ₹13,842.0 Cr | NA | NA | NA | Stock Analytics | |
MMTC | ₹11,307.0 Cr | 1.5% | -21.7% | 117.1% | Stock Analytics | |
MSTC | ₹6,180.8 Cr | 1.9% | -10.7% | 225.8% | Stock Analytics |
NOVARTIS INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NOVARTIS INDIA | 3.9% |
2.7% |
80.7% |
SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses